The nation records unprecedented whooping cough cases, with significant implications for vaccination practices and public health.
Australia is currently experiencing a notable surge in whooping cough cases, with over 14,000 recorded in 2025 and more than 57,000 in 2024, marking the highest annual total since 1991. This increase has raised concerns among health authorities and the public regarding vaccination coverage and the implications of waning immunity.
Whooping cough, or pertussis, is a highly infectious respiratory infection that circulates continuously in Australia, with epidemics expected every three to four years.
However, the current numbers are surpassing those typically anticipated during these periodic outbreaks.
The most affected regions include Queensland and Western Australia’s Kimberley region, which have reported significant increases in cases.
The rise in whooping cough cases is attributed to several factors, including the disruptions caused by
COVID-19 lockdowns in 2020 and 2021. These lockdowns not only reduced natural immunity to various diseases but also disrupted routine childhood vaccination services, contributing to a decline in public confidence in
vaccines.
Vaccine coverage in Australia, while still relatively high, has fallen below the national target of 95 percent, which is necessary to maintain herd immunity.
Even small declines in vaccination rates can significantly impact infection rates.
In addition to the situation in Australia, the United States has reported whooping cough cases at their highest levels since 1948, with several deaths, including those of infants, across various states.
Whooping cough poses the greatest risk to young babies, particularly those under six weeks of age, who cannot be vaccinated.
Infants younger than six months are at risk for severe outcomes, including hospitalization for respiratory support or complications such as pneumonia and seizures.
Despite this, the highest number of cases recorded in 2024 occurred in individuals aged 10 years and older, including adults.
The whooping cough
vaccine is effective in protecting against severe illness; however, its efficacy diminishes over time.
Primary vaccination occurs at six weeks, four months, and six months, providing substantial short-term protection.
Without booster doses, immunity may decline to less than 50 percent by the age of four.
Consequently, booster vaccinations at 18 months and four years are essential, along with booster recommendations for adults to mitigate infection risk, especially among caregivers of young infants.
Vaccination during pregnancy is advocated as an effective means to transfer protective antibodies to the unborn child, offering vital protection ahead of the infant's first vaccination.
If a mother is unable to receive the
vaccine during pregnancy, post-delivery vaccination is recommended to reduce the likelihood of maternal infection, providing indirect protection to the infant.
Highly contagious, whooping cough is estimated to be up to ten times more infectious than the flu.
Individuals vaccinated against whooping cough can still contract and transmit the disease.
Data indicates siblings, rather than parents, are often significant sources of pertussis transmission to infants, underscoring the importance of timely vaccination among family members.
Early symptoms of whooping cough resemble those of a common cold, including a runny nose, mild fever, and a persistent cough that typically worsens after a week, leading to characteristic coughing fits that may end with a sharp 'whoop' in older children and adults.
In infants, symptoms may present as brief apnea or color changes without the typical whoop.
Individuals diagnosed with whooping cough can remain contagious for up to three weeks after onset of symptoms, unless treated with antibiotics, which can shorten this to five days.
It is advised that people infected with the disease refrain from attending work, school, or childcare to protect others.
Consequently, health authorities recommend individuals check their vaccination records and ensure they are up to date, particularly if planning to care for young children or if experiencing protracted cough symptoms.
Boosters are emphasized as a preventive measure to help avert further outbreaks.